"The sector of medical cannabis has the potential to contribute importantly to the creation of jobs in Canada, especially in rural areas."
In Conversation
"We see a very positive future in R&D and biotechnology for Poland, and the current government has put forward a highly ambitious plan to grow these…
We aspire to move the company and the relationship with our customers from being a functional service provider to the strategic partner of choice in supplying the most…
"Poland is increasing in importance for AbbVie’s global clinical trials operations and the affiliate will continue to grow moving forward."
"While the market size renders India an attractive location for large foreign companies seeking to expand operations, and set up their R&D centers, I believe that…
"Bio is something that Japan has not always been on the frontline of"
"Our “next generation” service for clinical trials is a unique value proposition of IQVIA and is an area that many of our competitors are now attempting…
Interview: Brian O’Rourke – President and CEO, Canadian Agency for Drugs and Technologies in Health (CADTH)

"Our engagement with industry is equally proactive, collaborative, and transparent."
"The company invests a lot into education with doctors, using them as a middle man between the company and the patients."
"In Canada, we look to industry to partner with us on research activities. In addition, we also try to assist in building the right conditions (a…
"When looking at pharmaceuticals and the health sector, Serbia suffers from similar problems to the rest of Eastern Europe."
Interview: Darius Sinkevičius – Chairman of the Board, Lithuanian Association of Generic Pharmaceuticals Manufacturers (VGA)

"It bears mentioning that Lithuania has good level of inclusion of new chemical entities into the reimbursement list and, indeed, around 50 new products have been…